Log In
BCIQ
Print this Print this
 

VBY-376

  Manage Alerts
Collapse Summary General Information
Company Virobay Inc.
DescriptionReversible inhibitor of cathepsin B
Molecular Target Cathepsin B (CTSB)
Mechanism of ActionCathepsin B inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationLiver fibrosis
Indication DetailsTreat liver fibrosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today